Piramal Pharma Q2 FY27 profitability surge
Statements (10 of 11)
- Bullish
Piramal Pharma recorded a monthly gain of 12%.
- Bullish
Piramal Pharma reported a 15% increase in stock price following its Q2 results.
- Bullish
Piramal Pharma expects meaningfully higher profitability
- Bullish
Piramal Pharma shares surge 14% as Q2 profitability improves
- Bullish
Piramal Pharma upgrades FY27 revenue growth outlook to 19%-20%
- Neutral
Piramal Pharma Limited reported results for the second quarter and first half of fiscal year 2027
- Neutral
Piramal Pharma Limited reported results for the second quarter and half year ended September 30, 2026
- Bullish
Piramal Pharma reported a net profit of ₹5.58 crore in Q2 FY27, up from a loss of ₹99.2 crore the previous year.
- Bullish
Piramal Pharma upgraded its FY27 revenue growth outlook to 19%–20%.
- Bullish
Piramal Pharma's revenue grew 28% to ₹2,617 crore in Q2 FY27.
1 more statement on this development this week. The API returns all of them: GET /v2/statements?topic_id=549162fd-5103-4fda-b6aa-a3b61c9b8f04 Get a free API key ↗